Niall O'Donnell, Director at Mirum Pharmaceuticals, Inc. (MIRM), sold 600,000 shares at $19.99 ($11.9M) on 2022-11-11, disclosed to the SEC on 2022-11-15.
Open-market sale of $11.9M MIRM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.99 | 174,121 | $3.5M | 29.2% |
| 2 | $19.99 | 174,121 | $3.5M | 29.2% |
| 3 | $19.60 | 32,109 | $629K | 5.3% |
| 4 | $19.60 | 32,109 | $629K | 5.3% |
| 5 | $19.69 | 93,770 | $1.8M | 15.5% |
| 6 | $19.69 | 93,770 |
| $1.8M |
| 15.5% |
| Total | $19.85 avg | 600,000 | $11.9M | 100% |
| Filing → |
| RPHM | BUY | 2021-04-15 | $3.0M | — | Filing → |
| SPRB | BUY | 2020-10-16 | $3.8M | — | Filing → |
| MIRM | BUY | 2019-07-24 | $4.5M | — | Filing → |